Edition:
United States

Vitrolife AB (VITR.ST)

VITR.ST on Stockholm Stock Exchange

138.18SEK
7:48am EDT
Change (% chg)

1.06kr (+0.77%)
Prev Close
137.12kr
Open
138.00kr
Day's High
138.36kr
Day's Low
137.28kr
Volume
26,730
Avg. Vol
156,353
52-wk High
143.86kr
52-wk Low
100.40kr

Chart for

About

Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a... (more)

Overall

Beta: 0.77
Market Cap(Mil.): kr14,873.60
Shares Outstanding(Mil.): 108.55
Dividend: 0.74
Yield (%): 0.54

Financials

  VITR.ST Industry Sector
P/E (TTM): 53.97 40.23 33.88
EPS (TTM): 2.54 -- --
ROI: 21.64 14.34 13.21
ROE: 22.96 17.58 15.18

BRIEF-Vitrolife Q1 operating profit rises

* VITROLIFE AB Q1 OPERATING INCOME BEFORE DEPRECIATION AND AMORTISATION (EBITDA) AMOUNTED TO SEK 106 (95) MILLION Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)

Apr 24 2018

BRIEF-Vitrolife hikes dividend, Q4 EBITDA up yr/yr

* Q4 ‍SALES AMOUNTED TO SEK 271 (251) MILLION, CORRESPONDING TO AN INCREASE OF 8 PERCENT IN SEK​

Feb 08 2018

BRIEF-Vitrolife says Embryoscope approved for sales in China

* SAYS ‍HAS TODAY RECEIVED MARKET APPROVAL FOR TIME-LAPSE INCUBATOR EMBRYOSCOPE IN CHINA​ Source text for Eikon: Further company coverage: (Stockholm Newsroom)

Feb 01 2018

BRIEF-Vitrolife buys licensing rights for embryo transfer technology

* VITROLIFE ACQUIRES LICENSING RIGHTS TO TECHNOLOGY FOR EMBRYO TRANSFER

Jan 11 2018

Earnings vs. Estimates